{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:07:43Z","timestamp":1789092463571,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,6]],"date-time":"2027-06-06T00:00:00Z","timestamp":1812240000000},"content-version":"am","delay-in-days":278,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["K23HL175128\\u201301A1"],"award-info":[{"award-number":["K23HL175128\\u201301A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartandlung.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.hrtlng.2026.102870","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:44:57Z","timestamp":1780710297000},"page":"102870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Body mass index and baricitinib treatment effect in hospitalized adults with COVID-19: A secondary analysis of ACTT-2"],"prefix":"10.1016","volume":"79","author":[{"given":"Rachel","family":"Rigsby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3111-1972","authenticated-orcid":false,"given":"Timothy G.","family":"Gaulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrtlng.2026.102870_bib0001","doi-asserted-by":"crossref","first-page":"355","DOI":"10.15585\/mmwr.mm7010e4","article-title":"Body mass index and risk for COVID-19-related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death - United States, March-December 2020","volume":"70","author":"Kompaniyets","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0002","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus Remdesivir for hospitalized adults with Covid-19","volume":"384","author":"Kalil","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0003","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00134-023-07009-8","article-title":"Targeted immunomodulation: a primer for intensivists","volume":"49","author":"Janssen","year":"2023","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0004","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1513\/AnnalsATS.201404-159FR","article-title":"Physiological and management implications of obesity in critical illness","volume":"11","author":"Shashaty","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0005","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.202401-0101CP","article-title":"The rise of adaptive platform trials in critical care","volume":"209","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0006","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1378\/chest.10-0014","article-title":"The association between BMI and plasma cytokine levels in patients with acute lung injury","volume":"138","author":"Stapleton","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0007","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1164\/rccm.202503-0596RL","article-title":"Premorbid metabolic syndrome is associated with the hypoinflammatory phenotype in acute Respiratory distress syndrome and sepsis","volume":"211","author":"Bogart","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0008","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X241308027","article-title":"Impact of obesity on clinical outcomes and treatment continuation in rheumatoid arthritis patients receiving non-TNF-targeted therapies","volume":"16","author":"Park","year":"2024","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0009","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jbspin.2018.03.007","article-title":"Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: a systematic review and meta-analysis","volume":"86","author":"Shan","year":"2019","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0010","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archinte.168.15.1617","article-title":"The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004)","volume":"168","author":"Wildman","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0011","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1164\/rccm.201411-2125CP","article-title":"Implications of heterogeneity of treatment effect for reporting and analysis of randomized trials in critical care","volume":"192","author":"Iwashyna","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0012","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s00134-025-07873-6","article-title":"Sepsis subphenotypes, theragnostics and personalized sepsis care","volume":"51","author":"Antcliffe","year":"2025","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0013","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0014","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/gerona\/glp186","article-title":"body mass index, and abdominal obesity in older people","volume":"65A","author":"Hubbard","year":"2010","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0016","first-page":"1","article-title":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation","volume":"894","year":"2000","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0017","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1002\/sim.7501","article-title":"Practical recommendations for reporting Fine-Gray model analyses for competing risk data","volume":"36","author":"Austin","year":"2017","journal-title":"Stat Med"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0018","series-title":"Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis","author":"Harrell","year":"2015"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0019","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.29058","article-title":"Risk factors associated with In-hospital mortality in a US national sample of patients with COVID-19","volume":"3","author":"Rosenthal","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154262","article-title":"Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York","volume":"108","author":"Palaiodimos","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0021","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0022","first-page":"7","article-title":"JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality","author":"Stebbing","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0023","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/apt.16439","article-title":"The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programme","volume":"54","author":"Farraye","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.hrtlng.2026.102870_bib0024","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(22)01109-6","article-title":"Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis","volume":"400","year":"2022","journal-title":"Lancet"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956326001548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956326001548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:53:19Z","timestamp":1789091599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956326001548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":24,"alternative-id":["S0147956326001548"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2026.102870","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Body mass index and baricitinib treatment effect in hospitalized adults with COVID-19: A secondary analysis of ACTT-2","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2026.102870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102870"}}